Migraine headaches as a complication of the atrial fibrillation ablation procedure: case report
DOI:
https://doi.org/10.12775/JEHS.2023.42.01.005Keywords
migraine, neurological complications, ablation, atrial fibrilation, foramen ovaleAbstract
The balloon cryoablation (CA) procedure is an established method for the permanent treatment of atrial fibrillation (AF). Like other surgical interventions, it is associated with the potential development of early and late complications, including neurological ones such as migraine. We report a case of migraine headaches after the CA procedure. 25-year-old man with paroxysmal AF, without comorbidities, underwent balloon CA. On the second day after the procedure, the patient developed visual symptoms typical of migraine aura. After 30 minutes, these symptoms disappeared and appeared classic migraine headache attack. Similar episodes occurred over the following days. A focal central nervous system lesion was ruled out and a diagnosis of migraine with aura was made. The patient received a typical migraine attack treatment. The attacks ceased within two weeks. 3 months later during the follow-up visit at the neurology clinic no abnormalities were detected.
We decided to check if the migraine is a rare complication of AF ablation surgery. Many studies do not include migraine headaches at all in the neurological complications of ablation. However, based on some studies, it may seem that the incidence of migraine as a complication of ablation is underestimated.
References
Margulescu AD, Mont L. Persistent atrial fibrillation vs paroxysmal atrial fibrillation: differences in management. Expert Rev Cardiovasc Ther. 2017 Aug;15(8):601-618. doi: 10.1080/14779072.2017.1355237. Epub 2017 Jul 31. PMID: 28724315.
Kuck KH, Brugada J, Fürnkranz A, Metzner A, Ouyang F, Chun KR, Elvan A, Arentz T, Bestehorn K, Pocock SJ, Albenque JP, Tondo C; FIRE AND ICE Investigators. Cryoballoon or Radiofrequency Ablation for Paroxysmal Atrial Fibrillation. N Engl J Med. 2016 Jun 9;374(23):2235-45. doi: 10.1056/NEJMoa1602014. Epub 2016 Apr 4. PMID: 27042964.
Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Hamm CW, Sperzel J, Neumann T, Kuniss M. Second-generation cryoballoon ablation as a first-line treatment of symptomatic atrial fibrillation: Two-year outcome and predictors of recurrence after a single procedure. Int J Cardiol. 2018 May 15;259:76-81. doi: 10.1016/j.ijcard.2017.11.011. PMID: 29579615.
Akkaya E, Berkowitsch A, Zaltsberg S, Greiss H, Hamm CW, Sperzel J, Kuniss M, Neumann T. Five-year outcome and predictors of success after second-generation cryoballoon ablation for treatment of symptomatic atrial fibrillation. Int J Cardiol. 2018 Sep 1;266:106-111. doi: 10.1016/j.ijcard.2018.03.069. PMID: 29887425.
Noheria A, Roshan J, Kapa S, Srivathsan K, Packer DL, Asirvatham SJ. Migraine headaches following catheter ablation for atrial fibrillation. J Interv Card Electrophysiol. 2011 Apr;30(3):227-32. doi: 10.1007/s10840-010-9519-z. Epub 2010 Oct 19. PMID: 20957420.
Chilukuri K, Sinha S, Berger R, Marine JE, Cheng A, Nazarian S, Scherr D, Spragg D, Calkins H, Henrikson CA. Association of transseptal punctures with isolated migraine aura in patients undergoing catheter ablation of cardiac arrhythmias. J Cardiovasc Electrophysiol. 2009 Nov;20(11):1227-30. doi: 10.1111/j.1540-8167.2009.01525.x. Epub 2009 Jun 26. PMID: 19563357.
Patil N, Arora S, Davis L, Akoum NW, Chung MK, Sridhar AR. Incidence and Predictors of 30-day Acute Cerebrovascular Accidents Post Atrial Fibrillation Catheter Ablation (From the Nationwide Readmissions Database). Am J Cardiol. 2021 Jan 1;138:61-65. doi: 10.1016/j.amjcard.2020.10.020. Epub 2020 Oct 13. PMID: 33058801.
Pohl M, Hesszenberger D, Kapus K, Meszaros J, Feher A, Varadi I, Pusch G, Fejes E, Tibold A, Feher G. Ischemic stroke mimics: A comprehensive review. J Clin Neurosci. 2021 Nov;93:174-182. doi: 10.1016/j.jocn.2021.09.025. Epub 2021 Sep 20. PMID: 34656244
Jordaens L, Janse P, Szili-Torok T, Van Belle Y. Migraine accompagnée after transseptal puncture. Neth Heart J. 2010 Aug;18(7-8):374-5. doi: 10.1007/BF03091795. PMID: 20730006; PMCID: PMC2922785.
Khan J, Asoom LIA, Sunni AA, Rafique N, Latif R, Saif SA, Almandil NB, Almohazey D, AbdulAzeez S, Borgio JF. Genetics, pathophysiology, diagnosis, treatment, management, and prevention of migraine. Biomed Pharmacother. 2021 Jul;139:111557. doi: 10.1016/j.biopha.2021.111557. Epub 2021 May 17. PMID: 34243621.
Evans RW. Diagnostic Testing for Migraine and Other Primary Headaches. Neurol Clin. 2019 Nov;37(4):707-725. doi: 10.1016/j.ncl.2019.08.001. Epub 2019 Aug 31. PMID: 31563228
Soliman OI, Geleijnse ML, Meijboom FJ, Nemes A, Kamp O, Nihoyannopoulos P, Masani N, Feinstein SB, Ten Cate FJ. The use of contrast echocardiography for the detection of cardiac shunts. Eur J Echocardiogr. 2007 Jun;8(3):S2-12. doi: 10.1016/j.euje.2007.03.006. Epub 2007 Apr 25. PMID: 17462958.
Sardar P, Nairooz R, Chatterjee S, Wetterslev J, Ghosh J, Aronow WS. Meta-analysis of risk of stroke or transient ischemic attack with dabigatran for atrial fibrillation ablation. Am J Cardiol. 2014 Apr 1;113(7):1173-7. doi: 10.1016/j.amjcard.2013.12.027. Epub 2014 Jan 15. PMID: 24513472
Zhang Y, Wang H, Liu L. Patent Foramen Ovale Closure for Treating Migraine: A Meta-Analysis. J Interv Cardiol. 2022 Feb 2;2022:6456272. doi: 10.1155/2022/6456272. PMID: 35185398; PMCID: PMC8828350.
Kumar P, Kijima Y, West BH, Tobis JM. The Connection Between Patent Foramen Ovale and Migraine. Neuroimaging Clin N Am. 2019 May;29(2):261-270. doi: 10.1016/j.nic.2019.01.006. PMID: 30926116.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Michał Jakub Sekuła, Piotr Pawłucki, Anna Maciak; Jakub Chyła; Krzysztof Smoluchowski, Dorota Sokół, Paulina Piotrowska, Aleksandra Zimna
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
The periodical offers access to content in the Open Access system under the Creative Commons Attribution-NonCommercial-ShareAlike 4.0
Stats
Number of views and downloads: 2314
Number of citations: 0